{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:57:13Z","timestamp":1790906233728,"version":"4.1.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/wnf.0000000000000084","type":"journal-article","created":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T21:35:00Z","timestamp":1436650500000},"page":"144-146","source":"Crossref","is-referenced-by-count":17,"title":["A New Alternative Drug With Fewer Adverse Effects in the Treatment of Sydenham Chorea"],"prefix":"10.1097","volume":"38","author":[{"given":"Sevim","family":"\u015eahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Cansu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0883073807302614","article-title":"Sydenhams chorea: a clinical follow-up of 65 patients.","volume":"22","author":"Demiroren","year":"2007","journal-title":"J Child Neurol"},{"issue":"1","key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1528-1167.2006.00372.x","article-title":"Efficacy and safety of levetiracetam (up to 2000 mgday) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study.","volume":"47","author":"Tsai","year":"2006","journal-title":"Epilepsia"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/wnf.0b013e31803b9415","article-title":"Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia.","volume":"30","author":"Alemdar","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fneur.2014.00011","article-title":"Mechanisms of levetiracetam in the control of status epilepticus and epilepsy.","volume":"5","author":"Deshpande","year":"2014","journal-title":"Front Neurol"},{"key":"R6-6-20210203","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.wnf.0000186648.93612.a5","article-title":"Efficacy of levetiracetam in Huntington disease.","volume":"28","author":"De Tommaso","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"R7-6-20210203","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/mds.21061","article-title":"Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntingtons disease.","volume":"21","author":"Zesiewicz","year":"2006","journal-title":"Mov Disord"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mds.20377","article-title":"UFMG Sydenhams Chorea Rating Scale (USCRS): reliability and consistency.","volume":"20","author":"Teixeira","year":"2005","journal-title":"Mov Disord"},{"key":"R9-6-20210203","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.autrev.2014.01.036","article-title":"Diagnostic criteria of acute rheumatic fever.","volume":"13","author":"Burke","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"12","key":"R10-6-20210203","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1177\/0883073808319070","article-title":"Neurological adverse events associated with antipsychotic treatment in children and adolescents.","volume":"23","author":"Jerrell","year":"2008","journal-title":"J Child Neurol"},{"key":"R11-6-20210203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pediatrneurol.2009.02.013","article-title":"A family with paroxysmal nonkinesigenic dyskinesia: genetic and treatment issues.","volume":"41","author":"Szczaluba","year":"2009","journal-title":"Pediatr Neurol"},{"key":"R12-6-20210203","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mds.10118","article-title":"Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis.","volume":"17","author":"Chatterjee","year":"2002","journal-title":"Mov Disord"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-8749.2008.03170.x","article-title":"Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy.","volume":"51","author":"Vles","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.0013-9580.2004.02204.x","article-title":"Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine.","volume":"45","author":"Pisani","year":"2004","journal-title":"Epilepsia"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2003.11.065","article-title":"Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque.","volume":"485","author":"Bezard","year":"2004","journal-title":"Eur J Pharmacol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0000000000000084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:10:11Z","timestamp":1620976211000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201507000-00006"}},"subtitle":["Levetiracetam Efficacy in a Child"],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0000000000000084","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}